Context Therapeutics Inc (CNTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.28
• Market Cap: $223.27M
• EPS: $-0.24
• 52-Week High: $2.85
• 52-Week Low: $0.49

Market Sentiment

Context Therapeutics Inc currently has a Bullish sentiment score of 0.23.

About Context Therapeutics Inc

Context Therapeutics Inc. is a Boston-based late-stage biopharmaceutical company focused on developing innovative non-opioid therapies for chronic pain management. The company is poised to make significant advancements in the treatment landscape with its robust pipeline addressing critical unmet medical needs. By prioritizing the development of non-addictive solutions, Context Therapeutics is dedicated to enhancing patient outcomes and reducing dependency on opioids, positioning itself as a l...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Context Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CNTX pay dividends?

Context Therapeutics Inc (CNTX) does not currently pay a regular dividend.

What is CNTX's market cap?

Context Therapeutics Inc (CNTX) has a market capitalization of $223.27M with a current stock price of $2.28.